$BMI Cashflow Statement | Understand Stock

$BMI

$151.75 -$4.20 (2.69%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net earnings
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation
Amortization
Deferred income taxes
Noncurrent employee benefits
Stock-based compensation expense
Changes in:
Receivables
Inventories
Payables
Prepaid expenses and other assets
Other liabilities
Total adjustments
Net cash provided by operations
Investing activities:
Property, plant and equipment expenditures
Acquisitions, net of cash acquired
Proceeds from company owned life insurance plans
Net cash used for investing activities

Financing activities:
Dividends paid
Proceeds from exercise of stock options
Repurchase of common stock for treasury stock
Issuance of treasury stock
Net cash used for financing activities

Effect of foreign exchange rates on cash
(Decrease) increase in cash and cash equivalents
Cash and cash equivalents — end of year
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period
Supplemental disclosures of cash flow information:
Cash paid during the year for:
Income taxes
Interest
Property, plant and equipment acquired through operating lease
Property, plant and equipment accrued and unpaid

Comments